Romidepsin targets multiple survival signaling pathways in malignant T cellsBenigno C. Valdez, Börje S. Andersson|Blood Cancer Journal|2015Cited by 72
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell linesBenigno C. Valdez, Börje S. Andersson|Experimental Hematology|2012Cited by 45
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cellsBenigno C. Valdez, Börje S. Andersson|Oncotarget|2017Cited by 45
Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell linesBenigno C. Valdez, Börje S. Andersson|Blood Cancer Journal|2014Cited by 19
Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapyBenigno C. Valdez, Börje S. Andersson|Oncotarget|2016Cited by 19